EMERGENT SYSTEMS ANALYTICS
Reduce drug development costs and improve patient safety and drug efficacy with the next evolution of artificial intelligence - emergent intelligence. The estimated average cost of drugs reaching market approval is close to $2.6 billion according to the Tufts Center for the Study of Drug Development’s (CSDD). Emergent Systems Analytics, helps pharmaceutical and nutraceutical companies better target the best ingredient combination at the beginning of the product development life cycle, & gain... insight into effectiveness, contraindications & side-effects before testing. ESAs emergent intelligence solutions can reduce fail rate & cost at every phase of development, potentially saving millions of dollars in development cost. It gets pharmaceutical and nutraceutical products to market faster.
EMERGENT SYSTEMS ANALYTICS
Industry:
Artificial Intelligence Information Technology Intelligent Systems Life Science Machine Learning Nutraceutical Pharmaceutical
Founded:
2019-05-05
Website Url:
http://www.Emergentsa.com
Total Employee:
1+
Status:
Active
Contact:
860-460-6695
Email Addresses:
[email protected]
Technology used in webpage:
SPF Google Apps For Business Google DNS Google Domains Google Cloud DNS Weebly Hosting
Similar Organizations
Biospring Partners
Biospring is investing at the intersection of Life Sciences + Technology
Elipse Inteligencia Artificial
We are experts in the development of automated omnichannel communication solutions with artificial intelligence.
Omnia Biosystems
Omnia Biosystems is addressing challenging targets in oncology using artificial intelligence.
Official Site Inspections
http://www.Emergentsa.com
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.107
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
